References
- Karttunen E, Hervonen P, Hosseini A, et al. Incidence, mortality, and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019. Scand J. Urol. 2022:2022:1–7.
- Roupret M, Babjuk M, Comperat E, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018;73(1):111–122.
- Green DA, Rink M, Xylinas E, et al. Urothelial carcinoma of the bladder and the upper tract: disparate twins. J Urol. 2013;189(4):1214–1221.
- Sfakianos JP, Cha EK, Iyer G, et al. Genomic characterization of upper tract urothelial Carcinoma. Eur Urol. 2015;68(6):970–977.
- Hassler MR, Bray F, Catto JWF, et al. Molecular characterization of upper tract urothelial Carcinoma in the era of next-generation sequencing: a systematic review of the current literature. Eur Urol. 2020;78(2):209–220.
- Fujii Y, Sato Y, Suzuki H, et al. Molecular classification and diagnostics of upper urinary tract urothelial carcinoma. Cancer Cell. 2021;39(6):793–809.e8.
- Babjuk M, Burger M, Capoun O, et al. European association of urology guidelines on non-muscle-invasive BladderCancer (Ta, T1, and Carcinoma in Situ). Eur Urol. 2022;81(1):75–94.
- Witjes JA, Bruins HM, Cathomas R, et al. European association of urology guidelines on muscle-invasive and metastatic Bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79(1):82–104.
- Holmäng S, Johansson SL. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system. Urology. 2005;66(2):274–278.
- Liedberg F, Lauss M, Patschan O, et al. The importance of being grade 3: WHO 1999 versus WHO 2004 pathologic grading. Eur Urol. 2012;62(4):620–623.
- van Rhijn BWG, Hentschel AE, Bründl J, et al. Prognostic value of the WHO1973 and WHO2004/2016 classification systems for grade in primary Ta/T1 non-muscle-invasive bladder cancer: a multicenter european association of urology non-muscle-invasive bladder cancer guidelines panel study. Eur Urol Oncol. 2021;4(2):182–191.